Home/Filings/4/0001415889-23-004552
4//SEC Filing

GRAHAM RICHARD A 4

Accession 0001415889-23-004552

CIK 0001583107other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 7:34 PM ET

Size

4.7 KB

Accession

0001415889-23-004552

Insider Transaction Report

Form 4
Period: 2023-03-06
GRAHAM RICHARD A
SVP, Development
Transactions
  • Sale

    Ordinary Shares

    2023-03-06$10.05/sh2,323$23,346374,140 total
Footnotes (1)
  • [F1]This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001820036

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 7:34 PM ET
Size
4.7 KB